Willis Investment Counsel Maxcyte, Inc. Transaction History
Willis Investment Counsel
- $1.5 Billion
- Q3 2024
A detailed history of Willis Investment Counsel transactions in Maxcyte, Inc. stock. As of the latest transaction made, Willis Investment Counsel holds 405,471 shares of MXCT stock, worth $1.78 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
405,471
Previous 438,750
7.58%
Holding current value
$1.78 Million
Previous $1.72 Million
8.26%
% of portfolio
0.11%
Previous 0.12%
Shares
4 transactions
Others Institutions Holding MXCT
# of Institutions
124Shares Held
65.6MCall Options Held
1KPut Options Held
2K-
Cadian Capital Management, LP New York, NY8.19MShares$36 Million1.63% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$35.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.78MShares$25.4 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$22.2 Million7.62% of portfolio
-
Morgan Stanley New York, NY4.82MShares$21.2 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $448M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...